Retatrutide 4.0 combines Retatrutide with Cagrilintide and is studied for complementary triple-receptor and amylin signalling involving appetite, satiety, glucose regulation, energy expenditure and metabolic pathways. Research purposes only.

For more information, or if you are unsure about this product, please contact our team or complete the product-guidance questionnaire before purchasing.